BB Biotech's total assets for Q2 2026 were CHF3.09B, an increase of 16.98% from the previous quarter. DE:BBZA total liabilities were CHF5.29M for the fiscal quarter, a -32.68% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.